ACC 2022: Late-breaking Science Video Collection
Published: 05 April 2022
ACC 22: 5 Trials That Will Change Your Practice with Interventionalist, Dr Mirvat Alasnag
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science results and spotlight impactful data.
For a deeper dive into key clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA)talks with principal investigators in her regular Late-Breaker Discussion Series.
Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
View from the Thoraxcenter
Late-breaker Discussion Series
Director of Catheterization Laboratory
Dr. Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahd Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and a SCAI WIN member.
Dr. Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date, she has been a practicing Interventional Cardiologist at the King Fahd Armed Forces Hospital.
Dr. Alasnag is currently serving as a member of the Board of Trustees for SCAI and a member of the ACC Interventional Leadership Council. Dr. Alasnag…